KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Quest Diagnostics (DGX) over the last 13 years, with Q4 2024 value amounting to $306.0 million.

  • Quest Diagnostics' Accumulated Expenses rose 662.02% to $306.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $306.0 million, marking a year-over-year increase of 662.02%. This contributed to the annual value of $306.0 million for FY2024, which is 662.02% up from last year.
  • Quest Diagnostics' Accumulated Expenses amounted to $306.0 million in Q4 2024, which was up 662.02% from $287.0 million recorded in Q4 2023.
  • Over the past 5 years, Quest Diagnostics' Accumulated Expenses peaked at $460.0 million during Q4 2021, and registered a low of $287.0 million during Q4 2023.
  • Its 5-year average for Accumulated Expenses is $360.2 million, with a median of $356.0 million in 2020.
  • In the last 5 years, Quest Diagnostics' Accumulated Expenses skyrocketed by 5964.13% in 2020 and then plummeted by 2678.57% in 2023.
  • Quarter analysis of 5 years shows Quest Diagnostics' Accumulated Expenses stood at $356.0 million in 2020, then grew by 29.21% to $460.0 million in 2021, then dropped by 14.78% to $392.0 million in 2022, then decreased by 26.79% to $287.0 million in 2023, then grew by 6.62% to $306.0 million in 2024.
  • Its Accumulated Expenses was $306.0 million in Q4 2024, compared to $287.0 million in Q4 2023 and $392.0 million in Q4 2022.